HomeCYTO • NASDAQ
add
Altamira Therapeutics Ltd
Previous close
$0.45
Day range
$0.42 - $0.47
Year range
$0.40 - $17.20
Market cap
1.59M USD
Avg Volume
88.16K
P/E ratio
0.62
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.96M | -12.55% |
Net income | -2.17M | 19.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.46K | 32.05% |
Total assets | 8.07M | 30.06% |
Total liabilities | 1.75M | -78.19% |
Total equity | 6.32M | — |
Shares outstanding | 2.67M | — |
Price to book | 0.19 | — |
Return on assets | -60.68% | — |
Return on capital | -72.59% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.17M | 19.94% |
Cash from operations | -1.60M | 58.48% |
Cash from investing | 311.00 | 159.17% |
Cash from financing | 1.26M | -67.34% |
Net change in cash | -334.12K | -2,055.42% |
Free cash flow | -1.07M | 27.76% |
About
Founded
2003
Headquarters
Website
Employees
10
